Enable Biosciences INC
At a glance
Employees1-19
In business sinceNot reported
HeadquartersSouth San Francisco, CA
US patents2
SAM.gov UEID82RA1JMEBA8
CAGE code7FSW3
Incorporated inDE
- tools
- predictive medicine
- Type 1 Diabetes
- Stanford Healthcare
- Harvard Medical School
- California Department
- Public Health
- JDRF
- UC Berkeley
- 000 tests
Named on the company’s own website, read JUL 29, 2026
What they make
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
2 US patents granted 2021–2025, 2 of them in the five years to SEP 2025.
Biotechnology 2
- Reagents and methods for blocking non-specific interactions with nucleic acidsUS 12,428,675 · granted SEP 30, 2025
- Reagents and methods for blocking non-specific interactions with nucleic acidsUS 11,053,538 · granted JUL 6, 2021
Granted to Enable Biosciences Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Enable Biosciences INC | South San Francisco | CA | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.